197 related articles for article (PubMed ID: 9082178)
21. Angiotensin-converting enzyme inhibitor fetopathy.
Pryde PG; Sedman AB; Nugent CE; Barr M
J Am Soc Nephrol; 1993 Mar; 3(9):1575-82. PubMed ID: 8507813
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme inhibitors, an embryopathic class of drugs with unique properties: information for clinical teratology counselors.
Brent RL; Beckman DA
Teratology; 1991 Jun; 43(6):543-6. PubMed ID: 1882342
[No Abstract] [Full Text] [Related]
23. Angiotensin II receptor antagonist treatment during pregnancy.
Alwan S; Polifka JE; Friedman JM
Birth Defects Res A Clin Mol Teratol; 2005 Feb; 73(2):123-30. PubMed ID: 15669052
[TBL] [Abstract][Full Text] [Related]
24. [Hypertension in pregnancy. ACE inhibitors and angiotensin II receptor antagonists are contraindicated because of their potential fetotoxicity].
Partosch F; Stahlmann R
Med Monatsschr Pharm; 2011 Oct; 34(10):358-62. PubMed ID: 22010419
[No Abstract] [Full Text] [Related]
25. [The use of angiotensin converting enzyme (ACE) inhibitors during pregnancy clearly increases the risk of congenital malformations].
de Leeuw PW
Ned Tijdschr Geneeskd; 2006 Jul; 150(29):1605-7. PubMed ID: 16901062
[TBL] [Abstract][Full Text] [Related]
26. Recognition and management of angiotensin converting enzyme inhibitor fetopathy.
Sedman AB; Kershaw DB; Bunchman TE
Pediatr Nephrol; 1995 Jun; 9(3):382-5. PubMed ID: 7632538
[TBL] [Abstract][Full Text] [Related]
27. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors.
Cooper WO
J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502
[TBL] [Abstract][Full Text] [Related]
28. Gestational therapy with an angiotensin II receptor antagonist and transient renal failure in a premature infant.
Bass JK; Faix RG
Am J Perinatol; 2006 Jul; 23(5):313-7. PubMed ID: 16799914
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity.
Schaefer C
Birth Defects Res A Clin Mol Teratol; 2003 Aug; 67(8):591-4. PubMed ID: 14632309
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin-converting enzyme inhibitor fetopathy: long-term outcome.
Laube GF; Kemper MJ; Schubiger G; Neuhaus TJ
Arch Dis Child Fetal Neonatal Ed; 2007 Sep; 92(5):F402-3. PubMed ID: 17284475
[TBL] [Abstract][Full Text] [Related]
31. A complicated role for the renin-angiotensin system during pregnancy: highlighting the importance of drug discovery.
Darby M; Martin JN; LaMarca B
Expert Opin Drug Saf; 2013 Nov; 12(6):857-64. PubMed ID: 23915333
[TBL] [Abstract][Full Text] [Related]
32. Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth.
Bos-Thompson MA; Hillaire-Buys D; Muller F; Dechaud H; Mazurier E; Boulot P; Morin D
Ann Pharmacother; 2005 Jan; 39(1):157-61. PubMed ID: 15590878
[TBL] [Abstract][Full Text] [Related]
33. Outpatient use of cardiovascular drugs during pregnancy.
Andrade SE; Raebel MA; Brown J; Lane K; Livingston J; Boudreau D; Rolnick SJ; Roblin D; Smith DH; Dal Pan GJ; Scott PE; Platt R
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):240-7. PubMed ID: 18200619
[TBL] [Abstract][Full Text] [Related]
34. Exposure to angiotensin-converting enzyme inhibitors during first trimester: is it safe to fetus?
Yip SK; Leung TN; Fung HY
Acta Obstet Gynecol Scand; 1998 May; 77(5):570-1. PubMed ID: 9654182
[No Abstract] [Full Text] [Related]
35. [Teratogenic effects of ACE-inhibitors and angiotensin II receptor antagonists].
Sørensen AM; Christensen S; Jonassen TE; Andersen D; Petersen JS
Ugeskr Laeger; 1998 Mar; 160(10):1460-4. PubMed ID: 9520613
[TBL] [Abstract][Full Text] [Related]
36. Adverse reactions to drugs: angiotensin-converting enzyme inhibitors and pregnancy.
Birbari AE
J Med Liban; 1993; 41(2):99. PubMed ID: 8057352
[No Abstract] [Full Text] [Related]
37. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy.
Rey E; LeLorier J; Burgess E; Lange IR; Leduc L
CMAJ; 1997 Nov; 157(9):1245-54. PubMed ID: 9361646
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin converting enzyme inhibitors in pregnancy.
Mastrobattista JM
Semin Perinatol; 1997 Apr; 21(2):124-34. PubMed ID: 9201818
[TBL] [Abstract][Full Text] [Related]
39. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
Brilla CG; Rupp H; Maisch B
Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
[TBL] [Abstract][Full Text] [Related]
40. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
